Treatment potential for cholesterol management in patients with coronary heart disease in 15 European countries: Findings from the EUROASPIRE II survey-Reference-Cited by-同舟云学术

Treatment potential for cholesterol management in patients with coronary heart disease in 15 European countries: Findings from the EUROASPIRE II survey

Published:2008-04 Issue:2 Volume:197 Page:710-717
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Kotseva K.,Stagmo M.,De Bacquer D.,De Backer G.,Wood D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis;Law;BMJ,2003

2. Randomised trial of cholesterol lowering in 4444 people with coronary heart disease: the Scandinavian simvastatin survival study (4S);Lancet,1994

3. Effect of pravastatin on cardiovascular events in older people with myocardial infarction and cholesterol levels in the average range. Results of the cholesterol and recurrent events (CARE) trial;Lewis;Ann Intern Med,1998

4. Prevention of cardiovascular events and death with pravastatin in people with coronary heart disease and a broad range of initial cholesterol levels. The long-term intervention with pravastatin in ischaemic disease (LIPID) study group;N Engl J Med,1998

5. Treatment with atorvastatin to the National Cholesterol Educational Program goal versus ‘usual’ care in secondary coronary heart disease prevention. The Greek atorvastatin and coronary-heart-disease evaluation (GREACE) study;Athyros;Cur Med Res Opin,2002

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Appropriateness of Dyslipidemia Management Strategies in Post-Acute Coronary Syndrome: A 2023 Update;Metabolites;2023-08-04

2. Rhamnetin decreases the expression of HMG-CoA reductase gene and increases LDL receptor in HepG2 cells;Journal of Pharmacy & Pharmacognosy Research;2023-01-01

3. The Role of Genetics in Preventive Cardiology: Utility of Clinically Available Genetic Tests;Contemporary Cardiology;2020-12-22

4. Kayseri Şehir Hastanesi Kardiyoloji Kliniğinde Koroner Arter Hastalığı Olan Hastalarda Lipid Düşürücü İlaç Kullanımına Uyum ve LDL-Kolesterol Hedefine Ulaşma Düzeyleri;Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi;2020-01-31

5. Genetic and Non-Genetic Determinants of the Pharmacological Activity of Statins;Current Drug Metabolism;2016-10-21